This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Anticoagulants Industry

2010 through 2018 (includes corresponding Graph/Chart) II-76

 

Table 11: World Historic Review for Injectable Anticoagulants

by Geographic Region/ Country - US, Japan, Europe, and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-77

 

Table 12: World 15-Year Perspective for Injectable

Anticoagulants by Geographic Region/Country - Percentage

Breakdown of Dollar Sales for US, Japan, Europe, and Rest of

World Markets for Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart) II-78

 

Table 13: World Recent Past, Current & Future Analysis for

Injectable Anticoagulants by Product Segment - Unfractionated

Heparin and Low Molecular Weight Heparin Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-79

 

Table 14: World Historic Review for Injectable Anticoagulants

by Product Segment - Unfractionated Heparin and Low Molecular

Weight Heparin Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2004 through 2009

(includes corresponding Graph/Chart) II-80

 

Table 15: World 15-Year Perspective for Injectable

Anticoagulants by Product Segment - Percentage Breakdown of

Dollar Sales for Unfractionated Heparin and Low Molecular

Weight Heparin Markets Independently Analyzed for Years 2004,

2011 & 2018 (includes corresponding Graph/Chart) II-81

 

Table 16: World Recent Past, Current & Future Analysis for

Unfractionated Heparin by Geographic Region/Country - US,

Japan, Europe, and Rest of World Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2010 through 2018 (includes corresponding Graph/Chart) II-82

 

Table 17: World Historic Review for Unfractionated Heparin by

Geographic Region/Country - US, Japan, Europe, and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2004 through 2009 (includes

7 of 15

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,208.81 +17.44 0.10%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs